Hepatitis B and Liver Health Study in Zambia
Part of Digestive system, Infections clinical trials.
This research study follows people with hepatitis B (a liver infection) in Zambia to understand how their bodies respond to treatment and what happens to the virus over time. It includes people with hepatitis B alone, those also living with HIV, and those whose hepatitis B has cleared.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Live in Lusaka, Zambia, and be able to stay there for the length of the study
- Have hepatitis B confirmed by blood tests (or previously had it confirmed)
- Fall into one of five specific groups based on your hepatitis B status and treatment history
- Not have hepatitis C infection (another liver virus) that is currently active
- Not be pregnant or planning to become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to bring hepatitis B testing and care into the same clinics that already provide HIV services in Zambia. It aims to make it easier for people to get the hepatitis B help they need.
This study follows people who have both HIV and hepatitis B over time to better understand how the infection responds after starting treatment. Your information (and sometimes stored blood samples) helps researchers track changes from the start of therapy to about 2 years later.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This study looks at people with advanced HIV disease during their first months on antiretroviral therapy (ART). It aims to understand and improve care for those who start treatment when their immune system is weak.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This “real-life” study follows people with chronic hepatitis B to better understand their health over time. It may help researchers learn which factors affect outcomes in everyday care.
Hear when a new Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.